AIVITA Biomedical to Present Skin Care Technology and Products at 15th Annual South Beach Symposium
Company to highlight advancements in skin care and its PROVOQUETM line of anti-aging products at conference for skin care professionals.
IRVINE, Calif. – February 7, 2017 – AIVITA Biomedical today announced it will present details of its patented skin care technology and commercial line of skin care products at the upcoming South Beach Symposium in Miami Beach, Florida. The conference, taking place February 9-12 at the Loews Hotel Miami Beach, will be attended by physicians and practitioners seeking the latest therapies, technologies and procedures in medical and aesthetic skin care.
The South Beach Symposium is a 4-day conference which offers multiple educational tracks allowing medical professionals from both clinical and aesthetic dermatology practices to participate in focused education. AIVITA’s Chief Executive Officer, Hans S. Keirstead, Ph.D., will meet with key opinion leaders to discuss AIVITA’s new product lines. AIVITA’s Chief Science Officer, Gabriel Nistor, M.D., will lead a Continuing Medical Education course in Thursday’s session “Anti-Aging Medicine for the Dermatologist.” Dr. Nistor’s course, titled Stem Cells and Growth Factors in Skin Rejuvenation, will detail advancements in the understanding and application of human stem cell-derived growth factors for skin rejuvenation. On Friday, AIVITA Biomedical Scientific Advisory Board member Dr. Zoe Draelos, M.D. will chair a special symposium, “The Science of Topical Therapy, RX, OTC and Cosmeceuticals,” in which she will present research she conducted on AIVITA’s skin care advancements. The company will also have a scientific poster on display highlighting the findings of a clinical study which demonstrated improvements in several key areas of visible skin aging using the company’s proprietary formulation.
“Our manufacturing expertise has allowed us to generate high-purity cultures of early stage human skin cells from which we capture the complete set of factors, in their natural relative amounts, that mimic the environment of human skin development,“ said Aleksandra J Poole, Ph.D., Vice President of Research and Development. “We were excited to see how well it performed in clinical evaluations against several key indicators of facial aging.”
AIVITA Biomedical’s PROVOQUETM line of skin care products will be on display and available for purchase at the Company’s exhibit space. There, attendees can speak with sales staff and AIVITA scientists who developed AIVITA’s core skin care technology to learn more about the Company’s products and innovative technologies.
About AIVITA Biomedical
AIVITA Biomedical is a privately held company engaged in the advancement of commercial and clinical-stage programs utilizing curative and regenerative medicines. Founded in 2016 by pioneers in the stem cell industry, AIVITA Biomedical utilizes its expertise in stem cell growth and directed, high-purity differentiation to enable safe, efficient and economical manufacturing systems which support its commercial line of skin care products and therapeutic pipeline.